Researchers at UCLA have found a way to supercharge immune cells with a fuel source that tumors can't steal, dramatically ...

UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known ...

Adults with differentiated thyroid cancer who are using a GLP-1 for the treatment of diabetes or obesity do not have increased risk for cancer recurrence or progression vs. those not using a GLP-1, ...

Despite their renal and cardiovascular protection, GLP-1RA vs SGLT2i carries somewhat higher risks of renal cell carcinoma and urothelial cell carcinoma in adults with type 2 diabetes. The risks of ...

Scientists have made a breakthrough that could lead to effective treatments for lymphedema, a painful swelling condition for ...

A new discovery involving the larva of zebrafish shows promise for treating or preventing painful lymphoedema.

This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects ...

Diabetes mellitus, particularly type 2 diabetes, is associated with an increased risk of several malignancies, raising important questions at the interface ...

Nearly 40% of new cancer cases worldwide are potentially preventable, according to one of the first investigations 1 of its kind, which analysed dozens of cancer types in almost 200 countries. Cancer ...

The biggest stories of the day delivered to your inbox.

The incidence of colorectal cancer among users of GLP-1RAs was approximately 36% lower than that observed among aspirin users. The use of GLP-1 receptor antagonist (GLP-1RA) therapy has led to a ...

Obesity shaped Anna Olson's earliest notions of herself, when she saw a photo and thought, "Oh, I look different than the other kids." Olson's obesity began in toddlerhood, ran in her family, and left ...